Novelix Pharmaceuticals Ltd

536565·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap201.10 Cr
PE Ratio78.50
Volume—
Day High - Low—
52W High-Low92.00 - 38.00

Novelix Pharmaceuticals Ltd (536565): company summary

Novelix Pharmaceuticals Ltd (536565) is a micro-cap Retail company valued at ₹201 crore operating in Pharmacy Retail on the NSE and BSE.

Novelix Pharmaceuticals Ltd (536565) is a micro-cap Retail company valued at ₹201 crore operating in Pharmacy Retail on the NSE and BSE.

Financial performance
Revenue has been growing strongly at 66.3% a year over three years. Return on equity is 8.0%.
Valuation multiples
The stock trades at 78.5 times earnings, 3.06 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.0/10
Poor
Fair Value
Sign in to see
ROE
8.00%
Weak
P/E
78.50x
Expensive
Debt / Equity
0.09
Low
Industry
Retail
Pharmacy Retail
Overall View
Mixed

Price performance

52W₹38.00
₹92.00
DocStoX take

Supported by growth (9.0), but held back by valuation (0.0). Growth looks strong at 9.0, but that is offset by valuation at 0.0 and quality at 0.3. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Medium confidence
2.0
/10
Poor
Quality
Weak
ROE 8.0%
Valuation
Expensive
P/E 78.5×
Growth
Strong
Revenue +55.9% 5Y CAGR
Risk
Elevated
D/E 0.09
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹201 Cr
52W High / Low
₹92 / ₹38
Dividend Yield
0.00%
Promoter Holding
54.29%
EPS (TTM)
₹0.08
Book Value
₹23.08

Key highlights

  • Revenue compounding 56% a year
  • Low leverage — D/E 0.09
  • Loss-making in some of the last 5 years
  • Quality is weak (0.3/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Retail stocks · Pharmacy Retail

Explore Novelix Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Novelix Pharmaceuticals Ltd peers in Retail

Other Retail stocks on the NSE & BSE. See the full Retail sector list.

Related tools & concepts

Value Novelix Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing